Litcius/Paper detail

Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021

Heather Whitaker, Suzanne Elgohari, Cathy Rowe, Ashley Otter, Tim Brooks, Ezra Linley, Iain Hayden, Sonia Ribeiro, Jacqueline Hewson, Anissa Lakhani, Eleanor Clarke, Camille Tsang, Colin Campbell, Mary Ramsay, Kevin Brown, Gayatri Amirthalingam

2021Journal of Infection19 citationsDOIOpen Access PDF

Topics & Concepts

SeroprevalenceVaccinationMedicineCoronavirus disease 2019 (COVID-19)VirologyAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)SerologyImmunology2019-20 coronavirus outbreakPopulationNew englandInternal medicineOutbreakEnvironmental healthDiseasePolitical sciencePoliticsInfectious disease (medical specialty)LawSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and Hesitancy
Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021 | Litcius